abstract |
The present invention provides oligonucleotide analogs comprising modified interunit linkages and / or modified 3 'and / or 5'-end groups. The disclosed compounds are useful for treating diseases that inhibit protein expression or correct abnormal mRNA splicing products for beneficial therapeutic effects. |